We found that the levels of PPY, NAMPT, ADIPOQ, IL34, TAP1, RAC3, PDGFRA and AHNAK, combined with the risk scores, positively correlated with the progression of BLCA. Here, ADIPOQ is linked to bladder transitional cell carcinoma.